Diphtheria toxoid

Vaccines

Volumn , Issue , 2008, Pages 139-156

  Vitek, Charles R ^a,b   Wharton, Melinda ^c  

^a Centers for Disease Control and Prevention ^*  (Russian Federation)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886788394     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3611-1.50014-3     Document Type: Chapter

References (260)

1. A Zink, U Reischl, H Wolf, et al. (2001) Corynebacterium in ancient Egypt. Med History 45 267-272.
2. WH Holmes (1940) Diphtheria: History. Bacillary and Rickettsial Infections New York: Macmillan 291-305.
3. FW Andrewes, W Bulloch, SR Douglas, et al. (1923) Diphtheria: Its Bacteriology, Pathology and Immunology London: His Majesty's Stationery Office
4. PC English (1985) Diphtheria and theories of infectious disease. Pediatrics 76 1-9.
5. E Caulfield (1939) A true history of the terrible epidemic vulgarly called the throat distemper: which occurred in His Majesty's New England colonies between the years 1735 and 1740. Yale J Biol Med 11 226-272.
6. G Ramon (1923) Sur le pouvoir floculant et sur les proprietes immunisantes d'une toxin diphterique rendue anatoxique (anatoxine). C R Acad Sci 177 1338-1340.
7. MA Belsey, M Sinclair, MR Roder and DR LeBlanc (1969) Corynebacterium diphtheriae skin infections in Alabama and Louisiana: a factor in the epidemiology of diphtheria. N Engl J Med 280 135-141.
8. W Höfler (1991) Cutaneous diphtheria. Int J Dermatol 30 845-847.
9. B Afghani and HR Stutman (1993) Bacterial arthritis caused by Corynebacterium diphtheriae. Pediatr Infect Dis J 12 881-882.
10. PLF Zuber, E Gruner, M Altwegg and A von Graevenitz (1992) Invasive infection with nontoxigenic Corynebacterium diphtheriae among drug users [letter]. Lancet 339 1359.
11. I Poilane, F Fawaz, M Nathanson, et al. (1995) Corynebacterium diphtheriae osteomyelitis in an immunocompetent child: a case report. Eur J Pediatr 154 381-383.
12. O Patey, F Bimet, P Riegal, et al. (1997) for the Coryne Study Group Clinical and molecular study of Corynebacterium diphtheriae systemic infections in France. J Clin Microbiol 35 441-445.
13. M Reacher, M Ramsay, J White, et al. (2000) Nontoxigenic Corynebacterium diphtheriae: an emerging pathogen in England and Wales? Emerg Infect Dis 6 640-645.
14. MG Romney, DL Roscoe, K Bernard, et al. (2006) Emergence of an invasive clone of nontoxigenic Corynebacterium diphtheriae in the urban poor population of Vancouver, Canada. J Clin Microbiol 44 1625-1629.
15. D Holthouse, B Power, A Kermode and C Golledge (1998) Non-toxigenic Corynebacterium diphtheriae: two cases and review of the literature. J. Infect 37 62-66.
16. JS Anderson, FC Happold, JW McLeod and JG Thomson (1931) On the existence of two forms of diphtheria bacillus- B. diphtheriae gravis and B. diphtheriae mitis-and a new medium for their differentiation and for the bacteriological diagnosis of diphtheria. J Pathol Bacteriol 34 667-681.
17. DT Robinson and FN Marshall (1934) Investigations on the gravis, mitis, and intermediate types of C. diphtheriae and their clinical significance. J Pathol Bacteriol 38 73-89.
18. FH Top (Ed.) (1960) Diphtheria. Communicable and Infectious Diseases 4th ed St. Louis: CV Mosby 198-213.
19. HM Leete (1938) The heart in diphtheria. Lancet 1 136-139.
20. C Wesselhoeft (1940) Communicable diseases: cardiovascular disease in diphtheria. N Engl J Med 223 57-66.
21. DB Bethell, NM Dung, HT Loan, et al. (1995) Prognostic value of electrocardiographic monitoring of patients with severe diphtheria. Clin Infect Dis 20 1259-1265.
22. BA Stockins, FT Lanas, JG Saavedra and JA Opazo (1994) Prognosis in patients with diphtheritic myo-carditis and bradyarrhythmias: assessment of results of ventricular pacing. Br Heart J 72 190-191.
23. M Jayashree, N Shruthi and S Singhi (2006) Predictors of outcome in patients with diphtheria receiving intensive care. Indian Pediatrics 43 155-160.
24. EF Loukoushkina, PV Bobko, EV Kolbasova, et al. (1998) The clinical picture and diagnosis of diphtheritic carditis in children. Eur J Pediatr 145 528-533.
25. AM Ordian, ND Iushchuk, GN Karetkina, et al. (2000) Clinical and prognostic significance of disturbed global and regional contractility of left ventricle in diphtheria myocarditis [in Russian]. Klin Med 78 20-23.
26. T Celik, N Selimov, A Vekilova, et al. (2006) Prognostic significance of electrocardiographic abnormalities in diphtheritic myocarditis after hospital discharge: a long-term follow-up study. Ann Invasive Electrocardiol 11 28-33.
27. FR Ford (1973) Diseases of the Nervous System in Infancy, Childhood and Adolescence 6th ed. Springfield, IL: Charles C Thomas 716-721.
28. I Longina and M Donaghy (1999) Diphtheritic polyneuropathy: a clinical study and comparison with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 67 433-438.
29. MA Piradov, VN Pirogov, LM Popova and IA Avdunina (2001) Diphtheritic polyneuropathy: clinical analysis of severe forms. Arch Neurol 58 1438-1442.
30. G Funke, A von Graevenitz, JE Clarridge and KA Bernard (1997) Clinical microbiology of coryneform bacteria. Clin Microbiol Rev 10 125-159.
31. RJ Collier (2001) Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century. Toxicon 39 1793-1803.
32. RK Holmes (2000) Biology and molecular epidemiology of diphtheria toxin and the tox gene. J Infect Dis 181(Suppl 1), S156-S167.
33. AM Pappenheimer and DM Gill (1973) Diphtheria. Science 182 353-358.
34. RJ Collier (1975) Diphtheria toxin: mode of action and structure. Bacteriol Rev 39 54-85.
35. H Nakao, IK Mazurova, T Glushkevich and T Popovic (1997) Analysis of heterogeneity of Corynebacterium diphtheriae toxin gene, tox and its regulatory element, dtxR, by direct sequencing. Res Microbiol 148 45-54.
36. MP Schmitt (1997) Utilization of host iron sources by Corynebacterium diphtheriae: identification of a gene whose product is homologous to eukaryotic heme oxygenases and is required for the acquisi-tion of iron from heme and hemoglobin. J Bacteriol 179 838-845.
37. X Tao, N Schiering, H Zeng, et al. (1994) Iron, DtxR, and the regulation of diphtheria toxin expression. Mol Microbiol 14 191-197.
38. JG Naglich, JE Metherall, DW Russell and L Eidels (1992) Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 69 1051-1061.
39. J-H Cha, JS Brooke, KN Ivey and L Eidels (2000) Cell surface monkey CD9 antigen is a coreceptor that increases diphtheria toxin sensitivity and diphtheria toxin receptor affinity. J Biol Chem 275 6901-6907.
40. RE Morris, AS Gerstein, PF Bonventre and CB Saelinger (1985) Receptor-mediated entry of diphtheria toxin into monkey kidney (Vero) cells: electron micro-scopic evaluation. Infect Immun 50 721-727.
41. TJ Vaughan, JC Pascall and KD Brown (1992) Tissue distribution of mRNA for heparin binding epidermal growth factor. Biochem J 287 681-684.
42. Y Nakamura, K Handa, R Iwamoto, et al. (2001) Immunohistochemical distribution of CD9, heparin binding epidermal growth factor-like growth factor, and integrin a3a1 in normal human tissues. J Histochem Cytochem 49 439-444.
43. AM Pappenheimer Jr and JR Murphy (1983) Studies on the molecular epidemiology of diphtheria. Lancet 2 923-926.
44. H Lautrop (1950) Studies on the antigenic structure of Corynebacterium diphtheriae. Acta Pathol Microbiol Scand 27 443-447.
45. DGF Edward and VD Allison (1951) Diphtheria in the immunized with observations on a diphtheria-like disease associated with non-toxigenic strains of Corynebacterium diphtheriae. J Hyg 49 205-219.
46. M Kato (1970) Action of a toxic glycolipid of Corynebacterium diphtheriae on mitochondrial structure and function. J Bacteriol 101 709-716.
47. TP Wong and N Groman (1984) Production of diphtheria toxin by selected isolates of Corynebacterium ulcerans and Corynebacterium pseudotuberculosis. Infect Immun 43 1114-1116.
48. P Maximescu, A Oprisan, A Pop and E Potorac (1974) Further studies on Corynebacterium species capable of producing diphtheria toxin ( C. diphtheriae, C. ulcerans, C. ovis). J Gen Microbiol 82 49-56.
49. PD Meers (1979) A case of classical diphtheria, and other infections due to Corynebacterium ulcerans. J Infect 1 139-142.
50. MH Hust, B Metzler, U Schubert, et al. (1994) Toxische Diphtherie durch Corynebacterium ulcerans. Dtsch Med Wochenschr 119 548-553.
51. Centers for Disease Control and Prevention (1997) Respiratory diphtheria caused by Corynebacterium ulcerans—Terre Haute, Indiana, 1996. MMWR 46 330-332.
52. A Efstratiou, KH Engler, IK Mazurova, et al. (2000) Current approaches to the laboratory diagnosis of diphtheria. J Infect Dis 181(Suppl 1), S138-S145.
53. KH Engler, T Glushkevich, IK Mazurova, et al. (1997) A modified Elek test for detection of toxigenic corynebacteria in the diagnostic laboratory. J Clin Microbiol 35 495-498.
54. MJ Pallen (1991) Rapid screening for toxigenic Corynebacterium diphtheriae by the polymerase chain reaction. J Clin Pathol 44 1025-1026.
55. D Hauser, MR Popoff, M Kiredjian, et al. (1993) Polymerase chain reaction assay for diagnosis of potentially toxigenic Corynebacterium diphtheriae strains: correlation with ADP-ribosylation activity assay. J Clin Microbiol 31 2720-2723.
56. M Aravena-Romaán, R Bowman and G O'Neill (1995) Polymerase chain reaction for detection of toxigenic Corynebacterium diphtheriae. Pathology 27 71-73.
57. VM Mikhailovich, VG Melnikov, IK Mazurova, et al. (1995) Application of PCR for detection of toxigenic Corynebacterium diphtheriae strains isolated during the Russian diphtheria epidemic, 1990 through 1994. J Clin Microbiol 33 3061-3063.
58. A Efstratiou, KH Engler, CS Dawes and D Sesardic (1998) Comparison of phenotypic and genotypic methods for detection of diphtheria toxin among isolates of pathogenic corynebacteria. J Clin Microbiol 36 3173-3177.
59. H Nakao and T Popovic (1997) Development of a direct PCR assay for detection of the diphtheria toxin gene. J Clin Microbiol 35 1651-1655.
60. A Saragea and P Maximescu (1966) Phage typing of Corynebacterium diphtheriae. Bull World Health Organ 35 681-689.
61. R Rappuoli, M Perugini and E Falsen (1988) Molecular epidemiology of the 1984–1986 outbreak of diphtheria in Sweden. N Engl J Med 318 12-14.
62. MB Coyle, NB Groman, JQ Russell, et al. (1989) The molecular epidemiology of three biotypes of Corynebacterium diphtheriae in the Seattle outbreak, 1972–1982. J Infect Dis 159 670-679.
63. A De Zoysa, A Efstratiou, RC George, et al. (1995) Molecular epidemiology of Corynebacterium diphtheriae from northwestern Russia and surrounding countries studied by using ribotyping and pulsed-field gel electrophoresis. J Clin Microbiol 33 1080-1083.
64. T Popovic, SY Kombarova, MW Reeves, et al. (1996) Molecular epidemiology of diphtheria in Russia, 1985–1994. J Infect Dis 174 1064-1072.
65. H Nakao, JM Pruckler, IK Mazurova, et al. (1996) Heterogeneity of diphtheria toxin gene, tox, and its regulatory element, dxtR, in Corynebacterium diphtheriae strains causing epidemic diphtheria in Russia and Ukraine. J Clin Microbiol 34 1711-1716.
66. H Nakao and T Popovic (1998) Development of a rapid ribotyping method for Corynebacterium diphtheriae by using PCR single-strand conformation polymorphism: comparison with standard ribotyping. J Microbiol Methods 31 127-134.
67. PAD Grimont, F Grimont, A Efstratiou, et al. (2004) International nomenclature for Corynebacterium diphtheriae ribotypes. Res Microbiol 155 162-166.
68. T Popovic, IK Mazurova, A Efstratiou, et al. (2000) Molecular epidemology of diphtheria. J Infect Dis 181(Suppl 1), S168–77.
69. T Popovic, C Kim, J Reiss, et al. (1999) Use of molecular subtyping to document long-term persistence of Corynebacterium diphtheriae in South Dakota. J Clin Microbiol 37 1092-1099.
70. CK Marston, F Jamieson, F Cahoon, et al. (2001) Persistence of a distinct Corynebacterium diphtheriae clonal group within two communities in the United States and Canada where diphtheria is endemic. J Clin Microbiol 39 1586-1590.
71. KM Farizo, PM Strebel, RT Chen, et al. (1993) Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis 16 59-68.
72. GH Weaver (1921) Diphtheria carriers. JAMA 76 831-835.
73. AM Galazka and SE Robertson (1995) Diphtheria: changing patterns in the developing world and the industrialized world. Eur J Epidemiol 11 107-117.
74. KM Bisgard, IRB Hardy, T Popovic, et al. (1998) Respiratory diphtheria in the United States, 1980–1995. Am J Public Health 88 787-791.
75. Centers for Disease Control and Prevention (1999) Summary of notifiable diseases, United States, 1999. MMWR 48 33.
76. Centers for Disease Control and Prevention (2000) Summary of notifiable diseases, United States, 2000. MMWR 49 5.
77. Centers for Disease Control and Prevention (2001) Summary of notifiable diseases, United States, 2001. MMWR 50 5.
78. Centers for Disease Control and Prevention (2002) Summary of notifiable diseases, United States, 2002. MMWR 51 19.
79. Centers for Disease Control and Prevention (2003) Summary of notifiable diseases, United States, 2003. MMWR 52 19.
80. Centers for Disease Control and Prevention (2004) Summary of notifiable diseases, United States, 2004. MMWR 53 18.
81. Centers for Disease Control and Prevention (1997) Toxigenic Corynebacterium diphtheriae-northern plains Indian community, August–October 1996. MMWR 46 506-510.
82. TK Young (1984) Endemicity of diphtheria in an Indian population in northwestern Ontario. Can J Public Health 75 310-313.
83. CR Wilson, RI Casson, B Wherrett and N Fraser (1991) Toxigenic diphtheria in two isolated northern communities. Arctic Med Res (Suppl), 346-347.
84. Cahoon FE, Brown S, Jamieson F. Corynebacterium diphtheriae-toxigenic isolations from northeastern Ontario [abstract K-171]. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, September 28-October 1, 1997.
85. M Patel, F Morey, A Butcher, et al. (1994) The frequent isolation of toxigenic and non-toxigenic Corynebacterium diphtheriae at Alice Springs Hospital. Commun Dis Intell 18 310-311.
86. V Mortensen (1946) Occurrence of diphtheria in recent years, with a special view to the influence of the antidiphtheric vaccination. Acta Med Scand 125 283-293.
87. JV Walker (1947) Age and sex distribution of diphtheria in Oldenburg, Germany. Lancet 1 422-423.
88. S Madsen (1956) II. Diphtheria immunization. Dan Med Bull 3 116-121.
89. CR Vitek, SP Brisgalov, VY Bragina, et al. (1999) Epidemiology of epidemic diphtheria in three regions, Russia, 1994–1996. Eur J Epidemiol 15 75-83.
90. S Dittmann, M Wharton, C Vitek, et al. (2000) Successful control of epidemic diphtheria in the states of the former Union of Soviet Socialist Republics: lessons learned. J Infect Dis 181(Suppl 1), S10-S22.
91. HD Wright, HR Shone and JR Tucker (1941) Cross infection in diphtheria wards. J Pathol Bacteriol 52 111-128.
92. WE Crosbie and HD Wright (1941) Diphtheria bacilli in floor dust. Lancet 1 656-659.
93. MA Belsey (1970) Isolation of Corynebacterium diphtheriae in the environment of skin carriers. Am J Epidemiol 91 294-299.
94. P Larsson, B Brinkhoff and L Larsson (1987) Corynebacterium diphtheriae in the environment of carriers and patients. J Hosp Infect 10 282-286.
95. EE Jones, RJ Kim-Farley, M Algunaid, et al. (1985) Diphtheria: a possible foodborne outbreak in Hodeida, Yemen Arab Republic. Bull World Health Organ 63 287-293.
96. M Burnet and DO White (1972) Natural History of Infectious Disease 4th ed. London: Cambridge University Press 193-201.
97. U S. Bureau of the Census (1975) Historical Statistics of the United States, Colonial Times to 1970, Bicentennial Edition, Part 1 Washington, DC: US Department of Congress 58-63.
98. VA Metaxas Quiroga (1990) Diphtheria and medical therapy in late 19th century New York City. N Y State J Med 90 256-262.
99. EM Hammonds (1999) Childhood's Deadly Scourge: The Campaign to Control Diphtheria in New York City, 1880–1930 Baltimore: Johns Hopkins University Press
100. G Salisbury and L Salisbury (2003) The Cruelest Miles: The Heroic Story of Dogs and Men in a Race Against an Epidemic New York: WW Norton and Company
101. NE McKinnon (1942) Diphtheria prevented. R Cruickshank (Eds) Control of the Common Fevers London: Lancet 41-56.
102. J Lewis (1986) The prevention of diphtheria in Canada and Britain 1914–1945. J Social Hist 20 163-176.
103. K Stowman (1947) Diphtheria pandemic recedes. UN World Health Organ 1 60-67.
104. G Stuart (1945) A note on diphtheria incidence in certain countries. Br Med J 2 613-615.
105. SM Wheeler and AR Morton (1942) Epidemiological observations in the Halifax epidemic. Am J Public Health 32 947-956.
106. S Fleck, JW Kellam and AJ Klippen (1944) Diphtheria among German prisoners of war. Bull US Army Med Dept 74 80-89.
107. GF Brooks, JV Bennett and RA Feldman (1974) Diphtheria in the United States, 1959–1970. J Infect Dis 129 172-178.
108. RT Chen, CV Broome, RA Weinstein, et al. (1985) Diphtheria in the United States, 1971–1981. Am J Public Health 75 1393-1397.
109. JP Harnisch, E Tronca, CM Nolan, et al. (1989) Diphtheria among urban alcoholic adults: a decade of experience in Seattle. Ann Intern Med 111 71-82.
110. RV McCloskey, A Saragea and P Maximescu (1972) Phage typing in diphtheria outbreaks in the southwestern United States, 1968–1971. J Infect Dis 126 196-199.
111. Wharton M, Dittmann S, Strebel PM, Mortimer EA, (eds). Control of epidemic diphtheria in the newly independent states of the former Soviet Union. J Infect Dis 181(suppl 1):S1–S248, 2000.
112. V Skogen, VV Cherkasova, N Maksimova, et al. (2002) Molecular characterization of Corynebacterium diphtheriae isolates, Russian 1957–1987. Emerg Infect Dis 8 516-518.
113. M Wharton, IRB Hardy, C Vitek, et al. (1998) Epidemic diphtheria in the newly independent states of the former Soviet Union. WM Scheld, D Armstrong, JM Hughes (Eds) Emerging Infections. Vol. I Washington, DC: ASM Press 165-176.
114. P Tharmaphornpilas, P Yoocharoan, P Prempree, et al. (2001) Diphtheria in Thailand in the 1990s. J Infect Dis 184 1035-1040.
115. J Singh, RL Ichhpujani, S Prabha, et al. (1996) Immunity to diphtheria in women of childbearing age in Delhi in 1994: evidence of continued Corynebacterium diphtheriae circulation. Southeast Asian J Trop Med Public Health 27 274-278.
116. R Lodha, NR Dash, A Kapil, et al. (2000) Diphtheria in urban slums in north India. Lancet 355 204.
117. JA Walsh and KS Warren (1979) Selective primary health care: an interim strategy for disease control in developing countries [special article]. N Engl J Med 301 967-974.
118. World Health Organization, Department of Immunization, Vaccines and Biologicals (2005) WHO Vaccine-Preventable Diseases: Monitoring System. 2005 Global Summary Geneva: World Health Organization
119. World Health Organization, Department of Vaccines and Biologicals (2001) Vaccine-Preventable Diseases: Monitoring System. 2001 Global Summary Geneva: World Health Organization
120. E Roux and A Yersin (1888) Contribution à l’étude de la diphthérie. Ann Inst Pasteur 2 629-664.
121. E Behring (1890) Untersuchungen über das Zustandekommen der Diphtherie-Immunität bei Thieren. Dtsch Med Wochenschr 16 1145.
122. RA Kondratas (1982) Death helped write the biologics law. FDA Consum 16 23-25.
123. U. S. Food and Drug Administration (1985) Biological products; bacterial vaccines and toxoids; implementation of efficacy review Diphtheria antitoxin. Fed Reg 50 51079-51082.
124. Centers for Disease Control and Prevention (2004) Notice to Readers. Availability of diphtheria antitoxin through an investigational new drug protocol. MMWR 53 413.
125. M Kakita, T Takahashi, T Komiya, et al. (2006) Isolation of a human monoclonal antibody with strong neutralizing activity against diphtheria toxin. Infection and Immunity 74 3682-3683.
126. J-H Cha, JS Brooke, MY Chang and L Eidels (2002) Receptor-based antidote for diphtheria. Infect Immun 70 2344-2350.
127. HF Dowling (1973) Diphtheria as a model. JAMA 226 550-553.
128. CB Ker (1929) Infectious Diseases, A Practical Textbook, 3rd ed London: Oxford University Press
129. J Fibiger (1898) Om Serumbehandling of Difteri. Hosp-Tid 4.R 6 309-337.
130. A Hróbjartsson, PC Gøtzche and C Gluud (1998) The controlled clinical trial turns 100 years: Fibiger's trial of serum treatment of diphtheria. BMJ 317 1243-1245.
131. A Tasman, JE Minkenhof, HH Vink, et al. (1958) Importance of intravenous injection of diphtheria antiserum. Lancet 1 1299-1304.
132. T Smith (1909) Active immunity produced by so-called balanced or neutral mixtures of diphtheria toxin and antitoxin. J Exp Med 11 241-256.
133. E von Behring (1913) Über ein neues Diphtheries Schutzmittel. Dtsch Med Wochenschr 39 873-876.
134. WH Park (1937) Duration of immunity against diphtheria achieved by various methods. JAMA 109 1681-1684.
135. AT Glenny, CG Pope, H Waddington and U Wallace (1926) Immunological notes. XIII. The antigenic value of toxoid precipitated by potassium alum. J Pathol Bacteriol 29 38-39.
136. L Greenberg and DS Fleming (1948) The immunizing efficacy of diphtheria toxoid when combined with various antigens. Can J Public Health 39 131-135.
137. V Spiller, JM Barnes, LB Holt and DE Cullington (1955) Immunization against whooping-cough: combined v. separate inoculations. Br Med J 2 639-642.
138. MA Aprile and AC Wardlaw (1966) Aluminum compounds as adjuvants for vaccines and toxoids in man: a review. Can J Public Health 57 343-354.
139. KM Edwards and MD Decker (1997) Combination vaccines consisting of acellular pertussis vaccines. Pediatr Infect Dis J 16(Suppl), S97-S102.
140. U.S. Food and Drug Administration Thimerosal in vaccines. Online. Available at: http://www.fda.gov/cber/vaccine/thimerosal.htm
141. WHO Requirements for diphtheria, tetanus, pertussis and combined vaccines. WHO Technical Report Series No. 800, 1990, Annex 2.
142. WHO Recommendations for diphtheria, tetanus, pertussis and combined vaccines (Amendments 2003). WHO Technical Report Series No. 927, 2005, Annex 5.
143. JB Milstien, BG Gellin, M Kane, et al. (1996) Global DTP manufacturing capacity and capability. Status report: January 1995. Vaccine 14 313-320.
144. KM Edwards, BD Meade, MD Decker, et al. (1995) Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 96 548-557.
145. E Miller, P Waight, H Laurichesse, et al. (2001) Immunogenicity and reactogenicity of acellular diphtheria/tetanus/pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMR. Vaccine 19 3904-3911.
146. Centers for Disease Control and Prevention (2000) Use of diphtheria toxoid—tetatanus toxid—acellular pertussis vaccine as a five-dose series. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 49(No. RR-13), 1–8.
147. Centers for Disease Control and Prevention (1997) Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 46(RR-7), 1-25.
148. Centers for Disease Control and Prevention (2006) Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 55(RR-3), 1–43.
149. K Miyamura, S Nishio, A Ito, et al. (1974) Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration. J Biol Stand 2 189-201.
150. M Melville-Smith and A Balfour (1988) Estimation of Corynebacterium diphtheriae antitoxin in human sera: a comparison of an enzyme-linked immunosorbent assay with the toxin neutralization test. J Med Microbiol 25 279-283.
151. J Walory, P Grzesiowski and W Hryniewicz (2000) Comparison of four serological methods for the detection of diphtheria antitoxin. J Immunol Methods 245 55-65.
152. C von Hunolstein, H Aggerbeck, N Andrews, et al. (2000) European sero-epidemiology network: standardization of the results of diphtheria antitoxin assays. Vaccine 18 3287-3296.
153. M Barr, AT Glenny and KJ Randall (1950) Diphtheria immunization in young babies. A study of some factors involved. Lancet 1 6-10.
154. B Vahlquist (1949) Response of infants to diphtheria immunization. Lancet 1 16-18.
155. B Bjorkholm, M Granstrom, J Taranger, et al. (1995) Influence of high titers of maternal antibody on the serologic response of infants to diphtheria vaccination at three, five, and twelve months of age. Pediatr Infect Dis J 14 846-850.
156. Galazka AM The immunological basis for immunization: diphtheria. Expanded Programme on Immunization, World Health Organization, 1993.
157. EL Anderson, RB Belshe and J Bartram (1988) Differences and reactogenicity and antigenicty of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants. J Infect Dis 157 731-737.
158. WA Orenstein, JS Weisfeld and NA Halsey (1983) Diphtheria and tetanus toxoids and pertussis vaccine, combined. NA Halsey, CA de Quadros (Eds) Recent Advances in Immunization: A Bibliographic Review Washington, DC: Pan-American Health Organization 30-51.
159. MG Myers, CW Beckman, RA Vosdingh and WA Hankins (1982) Primary immunization with tetanus and diphtheria toxoids: reaction rates and immunogenicity in older children and adults. JAMA 248 2478-2480.
160. R-M Olander, T Wuorimaa, H Käyhty, et al. (2002) Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers. Vaccine 20 336-341.
161. Food and Drug Administration Aventis Pasteur. Menactra® briefing document. Bethesda, MD. US Department of Health and Human Services, Center for Biologic Evaluation and Research; September 22, 2004. Online. Available at: http://www.fda.gov/ohrms/dockets/ac/04/briefing/4072B1_1.pdf
162. J McVernon, J MacLennan, E Clutterbuck, et al. (2003) Effect of infant immunization with meningococcus serogroup C-CRM 197conjugate vaccine on diphtheria immunity and reactogenicity in pre-school aged children. Vaccine 21 2573-2579.
163. JM MacLennan, F Shackley, PT Heath, et al. (2000) Safety, Immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized control trial. JAMA 283 2795-2801.
164. MA Shelly, ME Pichichero and JJ Treanor (2001) Low baseline antibody level of diphtheria is associated with poor response to conjugated pneumococcal vaccine in adults. Scand J Infect Dis 33 542-544.
165. RA Insel (1995) Potential alterations in immunogenicity by combining or simultaneously administering vaccine components. Ann N Y Acad Sci 754 35-47.
166. R Dagan, J Eskola, C LeClerc and O Leroy (1998) Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun 66 2093-2098.
167. A Fattom, YH Cho, C Chu, et al. (1999) Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines. Vaccine 17 126-133.
168. J Ipsen (1946) Circulating antitoxin at the onset of diphtheria in 425 patients. J Immunol 54 325-347.
169. B Björkholm, M Böttiger, B Christensen and L Hagberg (1986) Antitoxin antibody levels and the outcome of illness during an outbreak of diphtheria among alcoholics. Scand J Infect Dis 18 235-239.
170. AM Pappenheimer (1958) The Schick test, 1913–1958. Int Arch Allergy Appl Immunol 12 35-41.
171. A Efstratiou and PAC Maple (1994) Laboratory Diagnosis of Diphtheria Copenhagen: World Health Organization, Expanded Programme on Immunization in the European Region
172. LW Miller, JJ Older, J Drake and S Zimmerman (1972) Diphtheria immunization: effect on carriers and the control of outbreaks. Am J Dis Child 123 197-199.
173. EK Marcuse and MG Grand (1973) Epidemiology of diphtheria in San Antonio, Texas, 1970. JAMA 224 305-310.
174. RT Chen, IRB Hardy, PH Rhodes, et al. (2000) Ukraine, 1992: first assessment of diphtheria vaccine effectiveness during the recent resurgence of diphtheria in the former Soviet Union. J Infect Dis 181(Suppl 1), S178-S183.
175. KM Bisgard, P Rhodes, IRB Hardy, et al. (2000) Diphtheria toxoid vaccine effectiveness: a case-control study in Russia. J Infect Dis 181(Suppl 1), S184-S187.
176. C Vitek, M Brennan, C Gotway, et al. (1999) Risk of diphtheria among schoolchildren in the Russian Federation in relation to time since last vaccination. Lancet 353 355-358.
177. M Brennan, C Vitek, P Strebel, et al. (2000) How many doses of diphtheria toxoid are required for protection of adults? Results of a case-control study among 40- to 49-year-old adults in the Russian Federation. J Infect Dis 181(Suppl 1), S193-S196.
178. V Tsu and DK Tyshchenko (2000) Case-control evaluation of an adult diphtheria immunization program. J Infect Dis 181(Suppl 1), S188-S192.
179. MJ Naiditch and AG Bower (1954) Diphtheria: a study of 1,433 cases observed during a ten-year period at Los Angeles County Hospital. Am J Med 17 229-245.
180. GF Brooks, JV Bennett and RA Feldman (1974) Diphtheria in the United States, 1959–1970. J Infect Dis 129 172-178.
181. MI Narkevich and LM Tymchakovskaia (1996) Specific features of the spread of diphtheria in Russia in the presence of mass immunization of children. Zh Mikrobiol Epidemiol Immunobiol Mar-Apr 25-29.
182. ML Quick, RW Sutter, K Kobaidze, et al. (2000) Risk factors for diphtheria: a prospective case-control study in the Republic of Georgia, 1995–1996. J Infect Dis 181(Suppl 1), S121–9.
183. JP Fox, L Elveback, W Scott, et al. (1971) Herd immunity: basic concept and relevance to public health immunization practices. Am J Epidemiol 94 179-189.
184. AM Galazka and SE Robertson (1996) Immunization against diphtheria with special emphasis on immunization of adults. Vaccine 14 845-857.
185. I Scheibel, MW Bentzon, PE Christensen and A Biering (1966) Duration of immunity to diphtheria and tetanus after active immunization. Acta Path Microbiol Scand 67 380-392.
186. M Tiru, HO Hallander, L Custafsson, et al. (2000) Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of booster. Vaccine 18 2295-2306.
187. J Taranger, B Trollfors, N Knutsson, et al. (2000) Vaccination of infants with a four-dose and a three-dose vaccination schedule. Vaccine 18 884-891.
188. R Booy, SJ Aitken, S Taylor, et al. (1992) Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet 339 507-510.
189. ME Ramsey, M Rao, NT Begg, et al. (1993) Antibody response to accelerated immunization with diphtheria, tetanus, pertussis vaccine. Lancet 342 203-205.
190. ME Ramsey, MJ Corbel, K Redhead, et al. (1991) Persistence of antibody after accelerated immunization with diphtheria/tetanus/pertussis vaccine. Br Med J 302 1489-1491.
191. WJ Edmunds, RG Pebody, H Aggerback, et al. (2000) The sero-epidemiology of diphtheria in Western Europe. Epidemiol Infect 125 113-125.
192. B Trollfors, N Knutsson, J Taranger, et al. (2006) Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for timing of a booster dose. Eur J Pediatr 165 14-18.
193. A Golaz, IB Hardy, TG Glushkevich, et al. (2000) Evaluation of a single dose of diphtheria-tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions. J Infect Dis 181(Suppl 1), S203-S207.
194. RW Sutter, IR Hardy, IA Kozlova, et al. (2000) Immunogenicity of tetanus-diphtheria toxoids (Td) among Ukrainian adults: implications for diphtheria control in the newly independent states of the former Soviet Union. J Infect Dis 181(Suppl 1), S197-S202.
195. T Rønne, R Valentelis, S Tarum, et al. (2000) Immune response to diphtheria booster vaccine in the Baltic States. J Infect Dis 181(Suppl 1), S213-S219.
196. N Khetsuriani, S Music, A Deforest and RW Sutter (2000) Evaluation of a single dose of diphtheria toxoid among adults in the Republic of Georgia, 1995: immunogenicity and adverse reactions. J Infect Dis 181(Suppl 1), S208-S212.
197. WHO (2006) Diphtheria vaccine: WHO position paper. Wkly Epidemiol Rec 81 24-32.
198. D Greco, S Salmaso, P Mastrantonio, et al. (1996) for the Progetto Pertosse Working Group A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 334 341-348.
199. L Gustafsson, HO Hallander, P Olin, et al. (1996) A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 334 349-355.
200. B Trollfors, J Taranger, T Lagergard, et al. (1995) A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med 333 1045-1050.
201. S Schmitt-Grohé, K Stehr, JD Cherry, et al. (1997) for the Pertussis Vaccine Study Group Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. Dev Biol Stand 89 113-118.
202. AE Tozzi and P Olin (1997) Common side effects in the Italian and Stockholm I trials. Dev Biol Stand 89 105-108.
203. MB Macko and CE Powell (1985) Comparison of the morbidity of tetanus toxoid boosters with tetanus-diphtheria toxoid boosters. Ann Emerg Med 14 33-35.
204. B Björkholm, FYI Wahl, M Granström and L Hagberg (1989) Immune status and booster effects of low doses of diphtheria toxoid in Swedish medical personnel. Scand J Infect Dis 21 429-434.
205. SGF Wassilak, WA Orenstein and RW Sutter (1994) Tetanus toxoid. SA Plotkin, EA Mortimer (Eds) Vaccines, 2nd ed Philadelphia: WB Saunders 76.
206. E Nathum, Y Lerman, D Cohen, et al. (1994) The immune response to booster vaccination against diphtheria toxin at age 18–21 years. Isr J Med Sci 30 600-603.
207. J Mortimer, M Melville-Smith and F Sheffield (1986) Diphtheria vaccine for adults. Lancet 2 1182-1183.
208. O Simonsen, K Kjeldsen, H-A Vendborg and I Heron (1986) Revaccination of adults against diphtheria I: responses and reactions to different doses of diphtheria toxoid in 30–70-year-old persons with low serum antitoxin levels. Acta Pathol Microbiol Immunol Scand C 94 213-218.
209. O Simonsen, M Klaerke, A Klaerke, et al. (1986) Revaccination of adults against diphtheria II: combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination. Acta Pathol Microbiol Immunol Scand C 94 219-225.
210. I Bartels, J Jüngert, S Lugauer, et al. (2001) Immunogenicity and reactogenicity of a single dose of a diphtheria-tetanus-acellular pertussis component vaccine (DTaP) compared to a diphtheria-tetanus toxoid (Td) and a diphtheria toxoid vaccine (d) in adults. Vaccine 19 3137-3145.
211. M Knuf, P Habermehl, J Faber, et al. (2006) Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life. Vaccine 24 5627-5636.
212. JM Langley, G Predy, R Guasparina, et al. (2007) An adolescent-adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4–6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine. Vaccine 25 1121-1125.
213. CL Collins, P Salt, N McCarthy, et al. (2004) Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children. Vaccine 22 4262-4269.
214. M Blennow, M Granström and A Strandell (1994) Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination. Vaccine 12 427-430.
215. A Mark and M Granström (1994) The role of aluminum for adverse reactions and immunogenicity of diphtheria-tetanus booster vaccine. Acta Paediatr 83 159-163.
216. A Mark, B Granström and M Granström (1995) Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminum-absorbed and fluid DT-vaccines. Vaccine 13 669-673.
217. R Alderslade, MH Bellman, NSB Rawson, et al. (1981) The National Childhood Encephalopathy Study. Whooping Cough: Reports from the Committee on the Safety of Medicines and the Joint Committee on Vaccination and Immunisation London: Department of Health and Social Security, Her Majesty's Stationery Office 79-154.
218. MH Bellman, EM Ross and DL Miller (1983) Infantile spasms and pertussis immunisation. Lancet 1 1031-1034.
219. Institute of Medicine (1994) Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Washington, DC: National Academy Press
220. Centers for Disease Control and Prevention (2006) Update: Guillain-Barré syndrome among recipients of Menactra® meningococcal conjugate vaccine—United States, June 2005–September 2006. MMWR 55 1120-1124.
221. J Dengrove, EJ Lee, DC Heiner, et al. (1986) IgG and IgG subclass specific antibody responses to diphtheria and tetanus toxoids in newborns and infants given DTP immunization. Pediatr Res 20 735-739.
222. JC Bernbaum, A Daft, R Anolik, et al. (1985) Response of preterm infants to diphtheria-tetanus-pertussis immunization. J Pediatr 107 184-188.
223. BA Koblin, TR Townsend, A Munoz, et al. (1988) Response of preterm infants to diphtheria-tetanus-pertussis vaccine. Pediatr Infect Dis J 7 704-711.
224. ME Ramsey, E Miller, LAE Ashworth, et al. (1995) Adverse events and antibody response to accelerated immunization in term and preterm infants. Arch Dis Child 72 230-232.
225. G Faldella, R Alessandroni, GM Magini, et al. (1998) The preterm infant's antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis. B vaccine 16 1646-1649.
226. KI Kirmani, G Lofthus, ME Pichichero, et al. (2002) Seven-year follow-up of vaccine response in extremely premature infants. Pediatrics 109 498-504.
227. B Bjorkholm, M Granström, J Taranger, et al. (1995) Influence of high titers of maternal antibody on the serologic response of infants to diphtheria vaccination at three, five and twelve months of age. Pediatr Infect Dis J 148 846-850.
228. AM Barkin, ME Pichichero, JS Samuelson and SZ Barkin (1985) Pediatric diphtheria and tetanus toxoids vaccine: clinical and immunologic response when administered as the primary series. J Pediatr 106 779-781.
229. ME Pichichero, RM Barkin and JS Samuelson (1986) Pediatric diphtheria and tetanus toxoids-adsorbed vaccine: immune response to the first booster following the diphtheria and tetanus toxoids vaccine primary series. Pediatr Infect Dis 5 428-430.
230. Centers for Disease Control and Prevention (1991) Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 40(RR-10), 1-28.
231. BJ Feery, AS Benenson, JRL Forsyth, et al. (1981) Diphtheria immunization in adolescents and adults with reduced doses of adsorbed diphtheria toxoid. Med J Aust 1 128-130.
232. GE King and SC Hadler (1994) Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious. Pediatr Infect Dis J 13 394-407.
233. Centers for Disease Control and Prevention (2002) General recommendations on immunization: recommendations of the Advisory Committee Immunization Practices (ACIP) and the American Academy of Family Physicians. MMWR 51(RR-2), 1-35.
234. P Howard and HD Riley (1966) An outbreak of diphtheria in eastern Oklahoma. J Oklahoma State Med Assoc 59 520-527.
235. RM Anderson (1992) The concept of herd immunity and the design of community-based immuni-zation programmes. Vaccine 10 928-935.
236. S Marlovits, R Stocker, A Efstratiou, et al. (2001) Seroprevalence of diphtheria immunity among injured adults in Austria. Vaccine 19 1061-1067.
237. PA Maple, A Efstratiou, RC George, et al. (1995) Diphtheria immunity in UK blood donors. Lancet 345 963-965.
238. R Rappuoli, A Podda, F Giovannoni, et al. (1993) Absence of protective immunity against diphtheria in a large proportion of young adults. Vaccine 11 576-577.
239. J Walory, J Grzesiowski and W Hryniewicz (2001) The seroprevalence of diphtheria immunity in healthy population in Poland. Epidemiol Infect 126 225-230.
240. PAC Maple, CS Jones, EC Wall, et al. (2001) Immunity to diphtheria and tetanus in England and Wales. Vaccine 19 167-173.
241. GM McQuillan, D Kruszon-Moran, A Deforest, et al. (2002) Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med 136 660-666.
242. B Christenson, U Hellström, SPE Sylvan, et al. (2001) Impact of a vaccination campaign on adult immunity to diphtheria. Vaccine 19 1133-1140.
243. IRB Hardy, S Dittmann and RW Sutter (1996) Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet 347 1739-1744.
244. NM Maksimova, NL Sukhorukova, GI Kostyuchenko, et al. (1987) Specific prophylaxis of diphtheria in adults in the focus of diphtheria infection. Zh Mikrobiol Epidemiol Immunobiol Aug 36-40.
245. V Tatochenko and IL Mitjushin (2000) Contraindications to vaccination in the Russian Federation. J Infect Dis 181(Suppl 1), S228-S231.
246. AM Galazka, SE Robertson and GP Oblapenko (1995) Resurgence of diphtheria. Eur J Epidemiol 11 95-105.
247. Centers for Disease Control (1991) Update on adult immunization: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 40(RR-12), 1-94.
248. PL Levin (1986) Diphtheria immunization: desirability of combined tetanus and diphtheria injection in wound management. Postgrad Med 79 139-140.
249. A Golaz, IR Hardy, P Strebel, et al. (2000) Epidemic diphtheria in the newly independent states of the former Soviet Union: implication for diphtheria control in the United States. J Infect Dis 181(Suppl 1), S237-S243.
250. DU Ekwueme, PM Strebel, SC Hadler, et al. (2000) Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997. Arch Pediatr Adoles Med 154 797-803.
251. F Zhou, J Santoli, ML Messonnier, et al. (2005) Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Arch Pediatr Adoles Med 159 1136-1144.
252. N Groman, J Schiller and J Russell (1984) Corynebacterium ulcerans and Corynebacterium pseudotuberculosis responses to DNA probes derived from corynephage and Corynebacterium diphtheriae. Infect Immun 45 511-517.
253. RJC Hart (1984) Corynebacterium ulcerans in humans and cattle in North Devon. J Hyg (Camb) 92 161-164.
254. AD Bostock, FR Gilbert, D Lewis and DCM Smith (1984) Corynebacterium ulcerans infection associated with untreated milk. J Infect 9 286-288.
255. H Mirchamsy, M Hamedi, G Fateh and A Sassani (1994) Oral immunization against diphtheria and tetanus infections by fluid diphtheria and tetanus toxoids. Vaccine 12 1167-1172.
256. H Aggerbeck, S Gizurarson, J Wantizin and I Heron (1997) Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine 15 307-316.
257. FC Robbins and JB Robbins (1986) Current status and prospects for some improved and new bacterial vaccines. Annu Rev Public Health 7 105-125.
258. C Frech, AK Hilbert, G Hartmann, et al. (2000) Physicochemical analysis of purified diphtheria toxoids: is toxoided then purified the same as purified then toxoided? Dev Biol 103 205-215.
259. M Diwan, A Misra, RK Khar and GP Talwar (1997) Long-term high immune response to diphtheria toxoid in rodents with diphtheria toxoid conjugated to dextran as a single contact point delivery system. Vaccine 15 1867-1871.
260. M Higaki, Y Azechi, T Takase, et al. (2001) Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid. Vaccine 19 3091-3096.